Variant report
Variant | esv3326087 |
---|---|
Chromosome Location | chr6:29947573-29951271 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:29937399..29939324-chr6:29949163..29951713,2 | K562 | blood: | |
2 | chr6:29941687..29943484-chr6:29948352..29949943,2 | K562 | blood: | |
3 | chr6:29949567..29952384-chr6:29955471..29958344,3 | K562 | blood: | |
4 | chr6:29950039..29951645-chr6:29953140..29954748,2 | K562 | blood: | |
5 | chr6:29943564..29948104-chr6:29950580..29953407,4 | MCF-7 | breast: | |
6 | chr6:29943871..29947343-chr6:29947953..29952410,7 | K562 | blood: | |
7 | chr6:29944005..29947343-chr6:29947938..29951140,5 | K562 | blood: | |
8 | chr6:29949567..29951883-chr6:29956360..29958897,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000204625 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370639312 | chr6:29947592-29947593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs372903049 | chr6:29947601-29947602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562257802 | chr6:29947649-29947650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377224992 | chr6:29947652-29947653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370796941 | chr6:29947667-29947668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs9260900 | chr6:29947714-29947715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs9260901 | chr6:29947734-29947735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9260902 | chr6:29947740-29947741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572862297 | chr6:29947758-29947759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs373653065 | chr6:29947759-29947760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs367755135 | chr6:29947769-29947770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541070559 | chr6:29947796-29947797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564462951 | chr6:29947861-29947862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533290702 | chr6:29947934-29947935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9260909 | chr6:29948041-29948042 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs569551197 | chr6:29948043-29948044 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs9260910 | chr6:29948069-29948070 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs9260911 | chr6:29948085-29948086 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs184289497 | chr6:29948149-29948150 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs1264812 | chr6:29948154-29948155 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs181796578 | chr6:29948155-29948156 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs9260912 | chr6:29948162-29948163 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | mRNA abundance |
23 | rs368162629 | chr6:29948215-29948216 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs371962857 | chr6:29948237-29948238 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs376261775 | chr6:29948294-29948295 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs559690852 | chr6:29948334-29948335 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs113193628 | chr6:29948344-29948345 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs62968960 | chr6:29948345-29948346 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs562652634 | chr6:29948358-29948359 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs2108691 | chr6:29948365-29948366 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs369755131 | chr6:29948396-29948397 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs9260914 | chr6:29948401-29948402 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs376420826 | chr6:29948417-29948418 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs542462890 | chr6:29948440-29948441 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs369404313 | chr6:29948444-29948445 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs115831477 | chr6:29948475-29948476 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs2735069 | chr6:29948482-29948483 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs114950540 | chr6:29948489-29948490 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs114528772 | chr6:29948503-29948504 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs139415400 | chr6:29948506-29948507 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs564353231 | chr6:29948514-29948515 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs201263929 | chr6:29948533-29948534 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs184626045 | chr6:29948540-29948541 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs9260915 | chr6:29948557-29948558 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs367582177 | chr6:29948585-29948586 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs563463523 | chr6:29948586-29948587 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs200037861 | chr6:29948588-29948589 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs372070657 | chr6:29948595-29948596 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs529303554 | chr6:29948600-29948601 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs376037490 | chr6:29948612-29948613 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21509527 | CNVD |
Melanoma | 17363583 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Rett syndrome | 21593744 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Glioma | 20126413 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:29945200-29948600 | Weak transcription | Small Intestine | intestine |
2 | chr6:29945200-29948600 | Weak transcription | Spleen | Spleen |
3 | chr6:29945400-29948800 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
4 | chr6:29945400-29950200 | Weak transcription | Right Atrium | heart |
5 | chr6:29945600-29948000 | Weak transcription | Colonic Mucosa | Colon |
6 | chr6:29945600-29948600 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
7 | chr6:29945600-29948600 | Weak transcription | Stomach Mucosa | stomach |
8 | chr6:29945600-29948800 | Weak transcription | Duodenum Mucosa | Duodenum |
9 | chr6:29945600-29966400 | Weak transcription | Pancreas | Pancrea |
10 | chr6:29945800-29948800 | Weak transcription | HepG2 | liver |
11 | chr6:29948600-29948800 | Enhancers | Colonic Mucosa | Colon |
12 | chr6:29948600-29948800 | Enhancers | Spleen | Spleen |
13 | chr6:29948600-29949200 | Enhancers | Small Intestine | intestine |
14 | chr6:29948600-29949400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr6:29948600-29949400 | Enhancers | Fetal Intestine Large | intestine |
16 | chr6:29948600-29949600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
17 | chr6:29948600-29949600 | Enhancers | Stomach Mucosa | stomach |
18 | chr6:29948800-29949000 | Enhancers | Duodenum Mucosa | Duodenum |
19 | chr6:29948800-29949400 | Enhancers | HepG2 | liver |
20 | chr6:29948800-29949800 | Enhancers | Rectal Mucosa Donor 29 | rectum |
21 | chr6:29949000-29949600 | Flanking Active TSS | Duodenum Mucosa | Duodenum |
22 | chr6:29949200-29949400 | Bivalent Enhancer | Fetal Heart | heart |
23 | chr6:29949200-29949600 | Enhancers | Fetal Intestine Small | intestine |
24 | chr6:29949400-29953400 | Weak transcription | HepG2 | liver |
25 | chr6:29949600-29949800 | Active TSS | Duodenum Mucosa | Duodenum |
26 | chr6:29949800-29950200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
27 | chr6:29950000-29950200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
28 | chr6:29950200-29953600 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
29 | chr6:29950400-29951200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
30 | chr6:29950600-29951200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |